Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Holders of 5% or more of KPRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kiora Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G/A | 9.99%363.7K shares | 0.00 ppfrom 9.99% | Nov 14, 20242 filings | Nov 14, 2025 | SEC |
| Rosalind Advisors, Inc. | 13G/A | 9.90%464.7K shares | 0.00 ppfrom 9.90% | Feb 10, 20253 filings | Feb 11, 2026 | SEC |
| ADAR1 Capital Management, LLC | 13G/A | 9.90%365.2K shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Nantahala Capital Partners Limited Partnership | 13G | 5.30%189.7K shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Kiora Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 20262:00 PM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%464.7K shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Jan 29, 20268:28 PM ET | Hirschman Orinand 1 other | 13G/A | 4.90%193.0K shares | −3.60 ppfrom 8.50%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:31 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%363.7K shares | 0.00 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Aug 14, 20257:47 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%365.2K shares | – | Jun 30, 2025 | SEC |
| Aug 14, 20254:36 PM ET | Nantahala Capital Partners Limited Partnership | 13G | 5.30%189.7K shares | New | Aug 8, 2025 | SEC |
| Aug 13, 20251:56 PM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%464.7K shares | 0.00 ppfrom 9.90% | Jun 30, 2025 | SEC |
| Feb 14, 20254:25 PM ET | Alyeska Investment Group, L.P.and 2 others | 13G/A | 2.50%75.6K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 202511:39 AM ET | Goldman Sachs Group Incand 1 other | 13G/A | 0.00%130 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 10, 20254:03 PM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%715.2K shares | – | Dec 31, 2024 | SEC |
| Feb 10, 20258:38 AM ET | Hirschman Orinand 1 other | 13G/A | 8.50%255.6K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 9.99%306.3K shares | New | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kiora Pharmaceuticals Inc shares.
No Form 144 notices for Kiora Pharmaceuticals Inc are on file.